Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Handheld Sensor for Anthrax and Ricin

By HospiMedica staff writers
Posted on 09 Jun 2004
A handheld sensor that can detect anthrax, ricin, and other potential bioterrorism pathogens is designed for use by first responders, hospital triage personnel, and military personnel.

The handheld system requires minimal technical expertise for operation, and users can be trained in under an hour to detect and identify multiple agents. More...
Tests can be performed in 10 minutes or less, and the self-contained cartridges may be stored to preserve a lasting record of analyses performed. The rechargeable battery-powered instrument is designed for use by users in full protective gear. The sensor is being developed by QTL Biosystems, LLC (Santa Fe, NM, USA), in conjunction with U.S. Army and public health organizations that will certify its capabilities.

"QTL has developed an instrument that combines excellent sensitivity with ease of use,” noted Dr. Alan Heeger, a member of QTL's Scientific Advisory Board and 2000 Nobel Prize winner in chemistry.

"Evaluation units will be available in August 2004, and the company plans to ship initial production systems in Q4, 2004,” said Dr. Duncan McBranch, chief operating officer of QTL Biosystems. QTL plans to deliver initial units with cartridges for anthrax and ricin, with Staphylococcal enterotoxin B to follow in early 2005. Additional cartridges will follow to provide a full complement of bacteria, protein toxins, and virus tests.

QTL Biosystems develops and markets bioassays designed to provide superior sensitivity, specificity, and speed in simple-to-use formats with low total cost of detection, toxins, bacteria, proteins, hormones, nucleic acids, and other biologic compounds.






Related Links:
QTL Biosystems

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.